Filed before 2025Filed 16 December 2021
Aro Biotherapeutics Co has sold $90.3M so far
Aro Biotherapeutics Co, a pharmaceuticals company based in Philadelphia, PA, has sold $90.3M so far in its equity round, according to a filing dated 16 December 2021.
Raises filed before 2025 are not checked for a public announcement.
- Filed
- 16 December 2021
- First filed
- 5 January 2021
- Round
- Equity round (amended filing)
- Amount sold
- $90.3M
- Offering size
- $90.3M
- Investors so far
- 14
- Based in
- Philadelphia, PA
Investors on the board
Firms come from the venture funds whose filings name a director of this company.
Who is on the board
2 directors of this company are named on venture funds' filings. Sign in free with Google to see who, the full filing, and a short list of rounds like this each morning.
Sign in with GoogleHow it compares
Larger than 89% of the 2,220 tracked raises with an amount filed in 2021, and than 95% of the 40 in pharmaceuticals.
Aro Biotherapeutics Co in public filings
| Filed | Filing | Sold | Raise |
|---|---|---|---|
| 28 Dec 2022 | New filing | $24M | Another raise |
| 16 Dec 2021 | Amended filing | $90.3M | This raise |
| 11 Jun 2021 | Amended filing | $64.3M | This raise |
| 16 Apr 2021 | Amended filing | $44.8M | This raise |
| 5 Jan 2021 | New filing | $42.3M | This raise |
More with Cowen Healthcare Investments on the board
Other unannounced rounds
- DVx Atomic Co.$18.5M
- Aperio Systems, Inc.$1.6M
- Twin Health, Inc.$59M
- Scoring Factory AI Inc.$500K
- Royal & Pelham, Inc.$5.4M
- SPECTRA Holdings US, Ltd.$2.5M
Seen it announced?
Send the link and the check will look at it.